Skip to content

Veralox Therapeutics

Site Navigation

  • Team
    • Management Team
    • Advisory Board
    • Board of Directors
  • Technology
  • Investors
  • News
  • Contact Us

News Veralox Therapeutics Appoints Lisa Beck as Chief Business Officer

February 25 , 2022 Wood Street Company News and Events

Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the appointment of Lisa Beck as Chief Business Officer.

Read more

Share

  • Facebook
  • Twitter
  • Tumblr
  • Pinterest
  • Reddit
  • LinkedIn
  • Email
Previous

Sidebar Navigation

  • Company News and Events

Archive

Search News

Veralox Therapeutics

Footer Navigation

  • Management Team
  • Technology
  • News
  • Contact Us

Follow Us

Copyright 2019 – 2022 Veralox Therapeutics  |  Privacy Policy | Website design by Wood Street, Inc.